Hodgkin Lymphoma—Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients
出版年份 2021 全文链接
标题
Hodgkin Lymphoma—Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 10, Issue 5, Pages 1125
出版商
MDPI AG
发表日期
2021-03-09
DOI
10.3390/jcm10051125
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dose-Intensification in Early Unfavorable Hodgkin Lymphoma: Long-Term Follow up of the German Hodgkin Study Group (GHSG) HD14 Trial
- (2020) Sarah Gillessen et al. BLOOD
- Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR
- (2020) Giancarlo Fatobene et al. JOURNAL OF CLINICAL ONCOLOGY
- KEYNOTE-204: Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) in relapsed or refractory classic Hodgkin lymphoma (R/R cHL).
- (2020) John Kuruvilla et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma
- (2020) Paul J. Bröckelmann et al. JAMA Oncology
- Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
- (2020) Richard T. Hoppe et al. Journal of the National Comprehensive Cancer Network
- Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
- (2020) Andrea Gallamini et al. JOURNAL OF CLINICAL ONCOLOGY
- Brentuximab Vedotin and ESHAP is Highly Effective as Second-Line Therapy for Hodgkin Lymphoma Patients (Long-Term Results of a Trial by the Spanish GELTAMO Group)
- (2019) R Garcia-Sanz et al. ANNALS OF ONCOLOGY
- PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study
- (2019) René-Olivier Casasnovas et al. LANCET ONCOLOGY
- Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study
- (2019) Radhakrishnan Ramchandren et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group
- (2019) Dennis A. Eichenauer et al. JOURNAL OF CLINICAL ONCOLOGY
- R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma
- (2018) Roosa Enni Inkeri Prusila et al. ACTA ONCOLOGICA
- Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2018) D A Eichenauer et al. ANNALS OF ONCOLOGY
- Mass cytometry of Hodgkin lymphoma reveals a CD4+exhausted T-effector and T-regulatory cell rich microenvironment
- (2018) Fathima Zumla Cader et al. BLOOD
- Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma
- (2018) Ann S. LaCasce et al. BLOOD
- Hodgkin lymphoma in elderly patients
- (2018) Sven Borchmann et al. CURRENT OPINION IN ONCOLOGY
- Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
- (2018) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
- (2018) Joseph M. Connors et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group
- (2018) Dennis A. Eichenauer et al. BLOOD
- ABVD or BEACOPP baseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)–Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial
- (2017) Christophe Fermé et al. EUROPEAN JOURNAL OF CANCER
- Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study
- (2017) Paul J. Bröckelmann et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial
- (2017) Marc P.E. André et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials
- (2017) Stephanie Sasse et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
- (2017) Robert Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
- (2017) Peter Borchmann et al. LANCET
- Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group
- (2017) Dennis A Eichenauer et al. LANCET ONCOLOGY
- Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
- (2017) Jonathan B. Reichel et al. Jove-Journal of Visualized Experiments
- Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study
- (2017) Raúl U Hernández-Ramírez et al. Lancet HIV
- Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma
- (2016) R. Chen et al. BLOOD
- The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. accuracy in a multicenter series of 372 patients
- (2015) Tzu-Hua Chen-Liang et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis
- (2015) Hugo J. A. Adams et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group
- (2015) Dennis A. Eichenauer et al. JOURNAL OF CLINICAL ONCOLOGY
- Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
- (2015) Karolin Behringer et al. LANCET
- Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Craig H Moskowitz et al. LANCET
- Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group
- (2015) D A Eichenauer et al. LEUKEMIA
- Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma
- (2015) John Radford et al. NEW ENGLAND JOURNAL OF MEDICINE
- Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma
- (2015) Michael Schaapveld et al. NEW ENGLAND JOURNAL OF MEDICINE
- The GHSG Approach to Treating Hodgkin’s Lymphoma
- (2015) Paul J. Bröckelmann et al. Current Hematologic Malignancy Reports
- Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis
- (2014) K. H. Xing et al. BLOOD
- High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed or refractory Hodgkin lymphoma: A systematic review with meta-analysis
- (2014) Michaela Rancea et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Characterizing bone marrow involvement in Hodgkin’s lymphoma by FDG-PET/CT
- (2014) Michal Weiler-Sagie et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003
- (2013) Pragna Patel et al. ANNALS OF INTERNAL MEDICINE
- ABVD in Older Patients With Early-Stage Hodgkin Lymphoma Treated Within the German Hodgkin Study Group HD10 and HD11 Trials
- (2013) Boris Böll et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment-Related Mortality in Patients With Advanced-Stage Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group
- (2013) Diana Wongso et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis
- (2013) Nicole Skoetz et al. LANCET ONCOLOGY
- Correction: Effect of Immune Reconstitution on the Incidence of HIV-Related Hodgkin Lymphoma
- (2013) Marc A. Kowalkowski et al. PLoS One
- Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study
- (2012) S. J. Proctor et al. BLOOD
- Hodgkin lymphoma
- (2012) Ralf Küppers et al. JOURNAL OF CLINICAL INVESTIGATION
- Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial
- (2012) Bastian von Tresckow et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma
- (2012) Tarec Christoffer El-Galaly et al. JOURNAL OF CLINICAL ONCOLOGY
- Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials
- (2012) Karolin Behringer et al. JOURNAL OF CLINICAL ONCOLOGY
- Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome
- (2011) K. J. Savage et al. BLOOD
- Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009
- (2011) J. Sjoberg et al. BLOOD
- Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma
- (2011) B. Boll et al. BLOOD
- A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era
- (2011) A. M. Evens et al. BLOOD
- MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
- (2011) Christian Steidl et al. NATURE
- ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
- (2011) Simonetta Viviani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964–2003 followed up to the end of 2006
- (2010) Hans H. Storm et al. ACTA ONCOLOGICA
- No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group
- (2010) K. Behringer et al. ANNALS OF ONCOLOGY
- Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
- (2010) Andrea Gallamini et al. BRITISH JOURNAL OF HAEMATOLOGY
- Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
- (2010) Andreas Engert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
- (2009) Andreas Engert et al. JOURNAL OF CLINICAL ONCOLOGY
- Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-Up
- (2009) Ronald C. Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of Hodgkin Lymphoma in Relapse after Autologous Stem Cell Transplant
- (2008) M. Crump Hematology-American Society of Hematology Education Program
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started